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Neural crestIn vertebrates, there are two related genes, Sulf1 and Sulf2 that code for extracellular heparan sulphate 6-0-
endosulphatases. These enzymes act to post-synthetically remodel heparan sulphate chains, generating
structural diversity of cell surface HSPGs; this activity provides an important mechanism to modulate
developmental cell signalling. Here we describe the expression and activity of Xenopus tropicalis Sulf2
(XtSulf2), which like XtSulf1, can act extracellularly to inhibit BMP4 and FGF4 signalling. Consistent with its
discrete expression in regions of the anterior developing nervous system, we found that overexpression of
XtSulf2 disrupts the expression of a set of neural markers and inhibits the migration of the neural crest. Using
a combination of grafting experiments and antisense morpholino based knockdown studies in Xenopus
embryos, we demonstrate that endogenous XtSulf1 and XtSulf2 play an important role during cranial neural
crest cell migration in vivo.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Heparan sulphate proteoglycans (HSPGs) are present on the cell
surface and in the extracellular matrix of all animals and are key
players in regulating cellular responses to signals (Lin, 2004; Turnbull
et al., 2001). HSPGs display long, unbranched chains of disaccharides
that are highlymodiﬁed by sulphation and interact withmany diverse
proteins, including growth factors and receptors.
It has been proposed that the particular sulphation patterns on
heparan sulphate (HS) can dictate the afﬁnity of HSPGs for a given
protein (Kreuger et al., 2006). Some modulation of HS sulphation
patterning happens during the biosynthesis of HSPGs by sulfotrans-
ferase enzymes acting in the Golgi, while further editing of HS
sulphation occurs post-synthetically by the HS-6-O-endosulphatases,
Sulf1 and Sulf2 (Dhoot et al., 2001; Morimoto-Tomita et al., 2002),
which are present and active at the cell surface (Ai et al., 2003, 2006).
Sulf1 and Sulf2 have been shown to have similar biochemical activity
and substrate speciﬁcity, as both of these enzymes remove the 6-O-
sulphate group from glucosamine in highly sulphated regions of HS
chains (Ai et al., 2006). In mouse, gene targeting of either Sulf1 or
Sulf2 results in very mild phenotypes, while targeting both genes is
more severe, consistent with the notion that these genes have
overlapping functions (Lamanna et al., 2006, 2008). Sulf1−/−;Sulf2−/− double mutant mice have reduced body weight and die shortly after
birth, a phenotype which is partially due to a defect in esophogeal
innervation resulting from impaired GDNF (glial derived neurotrophic
factor) signalling (Ai et al., 2007). GDNF is thought to maintain en-
teric neural crest precursors (Heuckeroth et al., 1998) and has also been
suggested to be a neural crest attractant (Young et al., 2001), how-
ever a role for Sulf1 or Sulf2 in neural crest migration has not been
investigated.
The neural crest (NC) migrates extensively from the dorsal neural
tube to give rise to diverse cell types throughout the embryo. This
process is highly ordered: the cephalic neural crest migrates in three
distinct streams toward their targets and inhibitorymechanisms, such
as signalling through EphB1 (Smith et al., 1997) and prevents the
intermingling of the streams. Recent work in frogs has shown in vivo
that homotypic contact inhibition of locomotion promotes the
movement of groups of neural crest cells in one direction (from
high to low cell density) and may be the mechanism that drives
directional migration (Carmona-Fontaine et al., 2008). At a single cell
level, this mechanism involves the activation of Dsh and RhoA at the
point of cell–cell contact which causes cell protrusions to collapse and
results in a change in cell polarity. In this way, closely associated
groups of NC cells move together with front cells invading mesoderm
and other non-NC tissue. In addition, there is good evidence that the
extracellular environment through which the NC migrates provides a
permissive substrate (Henderson and Copp, 1997), so that instructive
cues are provided by the presence of permissive and non-permissive
substrates. Indeed, the HSPG Syndecan-4 is required for normal,
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known activities of the Sulf1 class of extracellular sulphatases, we
hypothesise that Sulf modiﬁcation of local HSPG structure is
important for NC migration.
Recently, we described the expression of Xenopus tropicalis Sulf1
(XtSulf1) in the branchial arches (Freeman et al., 2008). Here, we
present our ﬁndings on the expression and activity of X. tropicalis
Sulf2, which like XtSulf1, can inhibit BMP and FGF signalling
extracellularly. We report that together these extracellular sulpha-
tases are essential for normal neural crest migration in vivo.
Materials and methods
Whole-mount in situ hybridization
Antisense digoxygenin (DIG) labelled RNA probes were synthe-
sised as described in (Supplementary data, Table 1). In situ
hybridization was carried out as modiﬁed from Harland (1991) and
brieﬂy described here: demembranated X. tropicalis embryos were
ﬁxed in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA, 1 mMMgSO4, 3.7%
formaldehyde) and stored in 100% ethanol at −20 °C. After
rehydration and treatment with 10 µg/ml Proteinase K, embryos
were washed in PBS and transferred to hybridisation buffer (50%
Formamide, 5× SSC pH 7, 1 mg/ml total yeast RNA, 100 µg/ml
Heparin, 1× Denhardts, 0.1% Tween 20, 0.1% CHAPS, and 10 mM
EDTA). After extensive washes at 60 °C, embryos were blocked in
Maleic Acid Buffer (MAB: 100 Mm maleic acid, 150 mM NaCl, 0.1%
Tween 20, pH 7.8)+20% heat treated lamb serum+2% Blocking
Reagent (Roche) for 2 h. This was then replaced with fresh solution
containing 1/2000 dilution of afﬁnity puriﬁed anti-digoxygenin
antibody coupled to AP (Roche) and rocked at 4 °C overnight. After
extensive washes in MAB, expression was visualised using BM purple
(Roche). Pigment was removed by bleaching embryos in 5% Hydrogen
peroxide in PBS.
Vibratome sections
Embryos were embedded in 4% noble agar and allowed to set at
4 °C. 50 µm sections were cut using a vibratome (Leica VT 1000 S)
using standard procedure. Sections were mounted in Hydromount
(National Diagnostics) on to Superfrost® Plus slides (VWR).
Western blots
Embryos were injected at the 2-cell stage with mRNA coding for
XtSulf1 or XtSulf2, or iFGFR1 with or without XtSulf2. Animal cap
explants were isolated at stage 8 and exposed to FGF4 protein or the
dimerising drug AP20187 (Pownall et al., 2003) and cultured until
stage 10, frozen and processed for Western blot analysis. In other
experiments, embryos were injected at the 2-cell stage with mRNA
coding for BMP4 or ALK3 alone or in combination with XtSulf2.
Animal cap explants were isolated at stage 8, cultured until stage 10,
frozen and processed for Western blot analysis. Embryos or explants
were homogenised in PhosphoSafe extraction buffer (Merck), run on
a 7.5% SDS PAGE gel and transferred onto PVDF membrane. Anti-
dpERK (1:4000; Sigma), anti-total ERK antibody (1/4000; Sigma)
anti-pSMAD 1/5/8 (1:500; Cell Signaling), and anti-GAPDH (1:106,
HyTest Ltd.) were detected using enhanced chemiluminescence (ECL)
(Roche).
rtPCR
Total RNA was extracted from either ten animal caps or ﬁve
whole embryos at Nieuwkoop and Faber (NF) stage 18 using TRI
REAGENT™ (Sigma) as per the manufacturer's protocol. cDNA was
synthesised using the AMV reverse transcriptase cDNA synthesis kit(Amersham) as per the manufacturer's protocol using the random
primers provided. Primers were designed against Xenopus laevis
ribosomal protein L8 (IMAGE: 4964907) as a loading control
(forward primer 5′GGGCTAGTCGACTTCTGCTGAA 3′; reverse primer
5′ATACGACCACCATCCAGCAAC 3′). Primers against NCAM were
designed (forward 5′ATGAATGGCAAAGGACTGGGAGAC 3′ and reverse
5′GTGGGCTTGGCTGTGGTTCTG 3′). PCR for detection of NCAM and L8
used an annealing temperature of 60 °C and a 30 s extension time for
25 cycles. PCR products were run on a 1% agarose gel.Antisense morpholino oligos
Antisense morpholino oligonucleotides (AMOs) were designed by
GeneTools and directed against the splice junction of exon 2/3 of
XtSulf1 (as described in Freeman et al., 2008; S1AMO 5′ ATAA-
GAAAACTCTCACCTAACTCC 3′) and the translational start of XtSulf2
(S2 AMO 5′ GAACAATATTCGCTGCTGCCCCATC 3′). AMOs were heated
at 55 °C for 5 min immediately before injection into one or both
blastomeres of X. tropicalis embryos at the two-cell stage. X. tropicalis
embryos were generated and cultured according to protocols on the
Harland website (http://tropicalis.berkeley.edu/home/). The control
MO was provided by GeneTools.Immunoﬂuorescence
X. laevis embryos were injected with mRNAs, cultured until NF
stage 11, and ﬁxed and stored in methanol+1% formaldehyde at
−20 °C. Embryos were then rehydrated and the vitelline membranes
were removed with forceps. The embryos were then permeabilized
PBS+Triton X-100 (Sigma) and blocked in PBS+1% BSA. Embryos
expressing Myc-tagged proteins were incubated overnight at 4 °C
with anti-Myc 9B11 antibody (Cell Signaling) at a 1/10,000 dilution in
PBS+1% BSA. These embryos were washed in PBS+0.1% Tween 20
and then incubated with secondary antibody, Alexa Fluor® 568 rabbit
anti-mouse IgG (H+L) antibody (Invitrogen, molecular probes) at a
1/4000 dilution. Embryos expressing GFP-tagged proteins were
processed as described above and incubated with anti-green
ﬂuorescent protein (GFP), rabbit IgG fraction, Alexa Fluor® 488 con-
jugate antibody (Invitrogen, molecular probes) at a 1/2000 dilution,
and from this point embryos are kept in the dark. The embryos are
then washed extensively in PBS+0.1% Tween 20 after which animal
caps were cut and mounted onto Superfrost® Plus slides in
Vectashield (Vector Laboratories) and photographed using a confocal
microscope (Axioplan 2 imaging LSM).Neural crest grafting
X. laevis embryoswere injected into the animal hemisphere of both
blastomeres at the 2-cell stage with either 3 ng of XtSulf2 mRNA
alone, or 1 ng of nucGFP mRNA alone, or co-injected with both 3 ng of
XtSulf2 and 1 ng of nucGFPmRNAs. At NF stage 14, ectoderm explants
of neural crest tissuewere dissected from the neural plate border with
an eyelash attached to a glass needle. Ectoderm from the same region
was removed from host embryos, leaving the mesoderm intact. The
donor neural crest was isotopically transplanted into the host
embryos, covered with a glass bridge and allowed to heal. A similar
set of experiments were carried out in X. tropicalis where a
combination of morpholino oligos and/or GFP mRNA were injected
into the animal hemisphere at the 2-cell stage and embryos were
allowed to develop until NF stage 14/15 when isotopic grafting was
carried out as described above. At NF stage 30, the migration of GFP
expressing grafts was visualised and photographed using a confocal
microscope (Axioplan 2 imaging LSM).
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Whole embryos were photographed using a SPOT SP401-230
camera (Diagnostic Instruments Inc.) and SPOT software with a Leica
MZFLIII microscope. Embryo sections were photographed using an
18.2 Colour Mosaic camera (Diagnostics Instruments Inc.) and SPOT
software with a Leica DM2500 microscope. Embryos expressing
ﬂuorescently tagged proteins were photographed using a confocal
microscope (Axioplan 2 imaging LSM).
Results
An EST database search identiﬁed a cDNA coding for X. tropicalis
Sulf2 (IMAGE: 5336642). This cDNA contains a 3499 bp insert that
includes all of the coding sequence. The XtSulf2 protein shares
approximately 80% identity to Human, Rat, Mouse and Quail Sulf2 at
the amino acid level and 60.7% identity with XtSulf1. The aligned
XtSulf1 and XtSulf2 sequences reveal a highly conserved catalytic
domain and COOH-terminal domain characteristic of this class of
extracellular sulphatases, with slightly divergent hydrophilic domain.
X. tropicalis Sulf2 clusters with other Sulf2 proteins in a neighbour-
joining phylogenetic tree of vertebrate Sulf1 and Sulf2 proteins
(Supplementary data, Fig. 1).
Zygotic expression of XtSulf2
The expression pattern of XtSulf2 during the development of X.
tropicaliswas determined usingwholemount in situ hybridisation and
is shown in Fig. 1. Zygotic expression of XtSulf2 is ﬁrst detected in the
anterior neural fold during mid-neurula stages (Figs. 1A and B). At NF
stage 22, XtSulf2 expression extends posteriorly to the hindbrain and
neural tube. Expression is also evident in the pineal gland and in the
mesendoderm underlying the cement gland primordium (arrow)
(Figs. 1C and D). By early tailbud stages, NF stage 25, XtSulf2 is
expressed in the ventral part of the hindbrain and neural tube and
expression is also seen in the midbrain–hindbrain junction (MHJ;
asterisk) in a dorsal to ventral stripe, as well as in the pineal gland
(arrowhead) and the mesendoderm subjacent to the cement gland
(arrows) (Fig. 1E). At stage 28 (Fig. 1F), XtSulf2 expression continues
in the midbrain, the MHJ (asterisk), and the hindbrain and crossFig. 1. Zygotic expression of XtSulf2. Zygotic transcripts for XtSulf2 are detected by wholemou
XtSulf2 are detected in the anterior neural tubemost promimently at the mid-hindbrain junc
neural tube, in the ventral midbrain and hindbrain and at themidbrain–hindbrain junction (a
(arrow in D and E). (E) At stage 25, XtSulf2 is expressed in the pineal gland (arrowhead), th
and the pineal gland (arrowhead). Strong expression continues in the ventral midbrain and h
neural retina. Expression is detected in the ventricular zone (VZ) of the midbrain and ventra
gland (arrowhead) olfactory placodes (arrows), and neural retina. (G–J, L–O) 50 µm vibrato
(H, J, M, O) 40× magniﬁcation. R is retina, VZ is ventricular zone, NT is neural tube, and Ncsections taken at the level of the eye (Figs. 1G and H) and the level of
hindbrain (Figs. 1I and J) show the ventral restriction of XtSulf2
expression. At stage 35, XtSulf2 is expressed in the nasal placodes
(arrows), the pineal gland, (arrowhead), the midbrain, the MHJ, and
the ventral hindbrain (Figs. 1 K–O).
Supplementary data Fig. 2 shows that XtSulf2 transcripts are also
present maternally and by gastrula stages are no longer detectable.
Initiation of zygotic expression occurs at neurula stages; expression
continues throughout tailbud stages and high levels of XtSulf2
transcripts are also detected in the adult brain. Interestingly, in contrast
to the very early and extensive expression of XtSulf1 in many meso-
dermal and neural tissues (Freeman et al., 2008), XtSulf2 is largely
restricted to anterior neural regions of the embryo. These ﬁndings are
consistent with the expression of Xsulf1 and Xsulf2 during X. laevis
development which has recently been described (Winterbottom and
Pownall, 2009).
XtSulf2 is localised at the cell membrane
To determine the sub-cellular localisation of XtSulf2, mRNA coding
for a GFP-tagged XtSulf2 was injected at the two-cell stage into the
animal pole of both blastomeres and cultured until NF stage 10 and
then subjected to immunohistochemistry with an anti-GFP ﬂuores-
cent antibody. mRNA coding for a nuclear localised GFP was injected
as a control (Fig. 2A). XtSulf2 is localised to the cell surface (Fig. 2B),
likely attached to the cell membrane via its hydrophilic domain as has
been shown for its quail homologue (Ai et al., 2006). Higher
magniﬁcation shows a punctuate distribution of XtSulf2–GFP which
indicates that the protein is restricted to foci on the cell membrane
(Fig. 2C). In order to compare the localisation of XtSulf1 and XtSulf2,
synthetic mRNAs coding for XtSulf2–GFP and an XtSulf1-Myc tag
fusion proteins were co-injected at the two-cell stage into the animal
pole of both blastomeres and analysed by immunohistochemistry
with anti-GFP and anti-Myc ﬂuorescent antibodies at NF stage 10.
Figs. 2D–F show that XtSulf1 is also localised at the cell membrane and
the overlay shows in yellow the extensive overlap of XtSulf1 and
XtSulf2 proteins at the cell surface. The FGF receptor is a transmem-
brane protein and previous studies using a tagged FGFR1have shown
expression of this fusion protein at the cell membrane (Pownall et al.,
1998). mRNAs coding for XtSulf2–GFP and an FGFR1-Myc fusionnt in situ hybridisation in X. tropicalis embryos. (A–B) At stage 18, zygotic transcripts for
tion (asterisk in B). (C–D) At stage 20, XtSulf2 is expressed in the ventral part of anterior
sterisk), and in themandibular mesenoderm underlying the presumptive cement gland
e mandibular mesendoderm subjacent to the cement gland (arrow), the MHJ (asterisk)
indbrain. (F–J) At stage 28, XtSulf2 is expressed in themandibular arch, pineal gland and
lly in the neural tube. (K) At stage 35, XtSulf2 is expressed in the MHJ (asterisk), pineal
me transverse sections through respectively (F) and (K). (G, I, L, N) 10× magniﬁcation,
is notochord.
Fig. 2. Localisation and activity of XtSulf2. RNAs coding for tagged proteins were injected into the animal hemisphere of both blastomeres of a two-cell X. laevis embryo and processed
for immunohistochemistry at NF stage 10. (A) Embryos injected with 1 ng of Nuc-GFP. (B and C) Embryos injected with 2 ng of XtSulf2–GFP. (D–F) Embryos co-injected with RNA
coding for XtSulf1-Myc (D) and XtSulf2–GFP. (E) The yellow regions in (F) show where XtSulf1 and XtSulf2 expression overlap. Embryos were co-injected with mRNA coding for
FGFR1-Myc (G) and XtSulf2–GFP (H) proteins. While both proteins appear associated with the membrane, they do not completely overlap (I). Western analysis shows in (J) that
XtSulf2 while injection of mRNA coding for XtSulf2 inhibits activation of dpERK by FGF4 protein, it has no effect on dpERK activation by the intracellularly drug induced iFGFR1.
(K) BMP4 activity was assayed byWestern blot analysis using antibodies against phospho-SMAD 1/5/8. The phosphorylation of SMAD 1/5/8 stimulated in animal caps by injection
of mRNA coding for BMP4 is down-regulated in animal caps co-expressing XtSulf2. However, animal caps expressing a constitutively active BMP4 receptor, Alk3 continue to express
phospho-SMAD 1/5/8 in the presence of XtSulf2, indicating that XtSulf2 acts upstream of the BMP4 receptor. (L) Neuralisation of animal caps was assayed using RT-PCR to detect
NCAM expression. Whole embryos (WE) express NCAM at NF stage 18, while control animal caps do not. Injection of mRNA coding for XtSulf2 results in the activation of NCAM
expression. Samples with water and without AMV Reverse Transcriptase (RT) were used as negative controls; L8 was used as a loading control.
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animal pole of both blastomeres and analysed by immunohistochem-
istry with anti-GFP and anti-Myc ﬂuorescent antibodies. Figs. 2H–I
show that both FGFR1and XtSulf2 proteins localise to the cell
membrane. Although the overlay (Fig. 2I) shows that XtSulf2 and
FGFR1are not completely overlapping, the FGFR1protein is tagged on
its C-terminal intracellular domain, so that the extracellular localisa-
tion of XtSulf2 (Ai et al., 2006) may explain the incomplete overlap of
FGFR1and XtSulf2.XtSulf2 can inhibit FGF and BMP4 signalling extracellularly
These observations on XtSulf2 localisation are consistent with the
ﬁndings that the related enzyme, Sulf1, can modulate FGF and BMP4
signalling extracellularly (Freeman et al., 2008;Wang et al., 2004).We
show here that XtSulf2 can also inhibit FGF and BMP signalling in a
ligand dependent manner. Fig. 2J is a Western blot showing levels of
ERK 1/2 phosphorylation (dpERK) as a readout of FGF signalling.
Uninjected, untreated animal caps exhibit very little ERK 1/2
phosphorylation, as do animal caps overexpressing XtSulf2, while
animal cap explants cultured in the presence of FGF4 protein
accumulate high levels of dpERK. However, in animal caps injected
with XtSulf2 and cultured in presence of FGF4 protein, activation of
dpERK is inhibited. This shows that animal caps are unable to respond
to FGF4 ligand when XtSulf2 is overexpressed. Moreover, we show
that XtSulf2 does not inhibit the intracellularly activated iFGF-R1.
Fig. 2J shows that the effects of the dimerising drug AP20187, which
acts inside the cell to bring together iFGFR1proteins to induce tyrosine
kinase activity and activate the downstream MAPK pathway, is not
affected by XtSulf2. These results indicate that XtSulf2 (as shown for
XtSulf1 and QSulf1 (Freeman et al., 2008; Wang et al., 2004)) actsoutside the cell and upstream of FGF receptor activation to inhibit FGF
signalling.
We have observed the formation of cement glands in XtSulf2
injected animal caps (data not shown), which suggests that these
explants may be neuralised by the inhibition of BMP4 signalling.
Western blotting to detect SMAD1/5/8 phosphorylation was used
to determine if XtSulf2 can inhibit BMP4 signalling in animal cap
explants. Fig. 2K is a western blot that shows uninjected animal caps
have very low levels of pSMAD 1/5/8, while injection of BMP4 mRNA
strongly induces SMAD 1/5/8 phosphorylation. In contrast, animal
caps co-injected with BMP4 and XtSulf2 mRNA show very low levels
of SMAD 1/5/8 phosphorylation indicating that XtSulf2 can inhibit
BMP4 signalling in animal caps. Alk3 is a constitutively active BMP
receptor that activates the intracellular BMP signalling pathway
independent of ligand. Animal caps injected with mRNA coding for
Alk3 activate SMAD 1/5/8 phosphorylation. In animal caps co-
injected with Alk3 and XtSulf2 mRNA, SMAD 1/5/8 phosphorylation
is not affected, suggesting that XtSulf2 acts extracellularly to inhibit
BMP signalling, upstream of BMP receptor activation. To further
investigate the effects of XtSulf2 on BMP signalling, we assayed
whether or not XtSulf2 can neuralise animal caps, using semi-
quantitative rtPCR to detect for NCAM expression (Fig. 2L). Control
animal caps do not express NCAM when cultured on their own;
however animal caps injected with mRNA coding for XtSulf2 activate
NCAM expression, consistent with the notion that the Sulf enzymes
inhibit BMP4 as well as FGF signalling (Freeman et al., 2008).
Overexpression of XtSulf2 disrupts the expression pattern of neural
markers
Given the speciﬁc expression of XtSulf2 in anterior neural regions
of the developing embryo, and its ability to impact on FGF and BMP
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of overexpressing XtSulf2 on the expression of a set of neural markers
was analysed. X. tropicalis embryos were unilaterally injected with
0.5 ng of XtSulf2 mRNA into the animal hemisphere at the two-cell
stage, cultured until tailbud stages (NF stage 28), and ﬁxed for
analysis by in situ hybridisation. We observe that overexpression of
XtSulf2 disrupts the normal boundaries of expression of some neural
markers.
En2 is expressed in the MHJ (Fig. 3A), and in embryos unilaterally
injected with mRNA coding for XtSulf2 the expression domain of
En2 is enlarged and shifted posteriorly (Fig. 3B). The normal ex-
pression of Isl1 in the pineal gland and anterior domain of the heart is
not altered in embryos overexpressing XtSulf2, while Isl1 expression
in the profundal and trigeminal ganglion extends, is broader and less
distinct (Figs. 3C and D, arrowhead). Krox20 is normally expressed
in rhombomeres 3 (r3) and 5 (r5) and in a subset of neural crest
cells migrating from r5 (white arrowhead, Fig. 3E), while in embryos
unilaterally injected with XtSulf2 mRNA, Krox20 expression in the
r5 and the migrating neural crest cells is shifted posteriorly
(Figs. 3F and G).
Lim1 is expressed in the hind brain, neural tube and pronephros
(Fig. 3H). In embryos unilaterally injected with XtSulf2 mRNA, Lim1
expression in the hindbrain and neural tube appears normal; however
the expression domain of Lim1 in the pronephros is shorter and widerFig. 3. Overexpression of XtSulf2 affects the expression of a number of genes expressed in a
tropicalis embryo was injected with 0.5 ng of XtSulf2 mRNA, embryos were allowed to devel
(E–G), Lim1 (H–I), NeuroD (J–L), Otx2 (M–N), Pax6 (O–Q), Slug (R–S), Sox3 (T–U), and Sox8
in the profundal and trigeminal placodes shifts posteriorly (black arrowheads) as does the
posteriorly (E–Fwhite arrowheads) as does the expression in r5 (G black lines). Lim1 express
profundal and trigeminal placodes is disrupted (J–K red arrowheads), and expression in the o
expression is restricted in the midbrain (M–N black lines). Pax6 expression is ectopically exp
at the leading edge of neural crest migration remains closer to the neural tube than in c
laterally (T–U black lines). Sox8 expression in the anterior and posterior branchial arches
neural tube than in controls (V–W green arrowhead). (A–B, G, Q) are dorsal views of emb
to the left. (L) is an anterior view of embryo in (J–K), dorsal at the top. Asterisks indicatthan in control embryos (Fig. 3I). NeuroD is expressed in the pineal
gland, olfactory and lens placodes, profundal and trigeminal nerves,
and the epibranchial placodes (Fig. 3J), while in embryos unilaterally
injected with XtSulf2 mRNA, this expression is disrupted (red
arrowheads, Fig. 4K) and the ganglia do not migrate as ventrally as
control ganglia (Fig. 3L). Furthermore, the olfactory placodes appear
to merge with the lens placodes (yellow arrowhead). Otx2 is
expressed in the anterior brain and developing eye placodes
(Fig. 3M), while in embryos unilaterally injected with XtSulf2, Otx2
expression in the midbrain does not extend as far posteriorly as in
controls (Fig. 3N). Pax6 is normally expressed in the anterior neural
tissue as well as hindbrain and neural tube (Fig. 3O), while in embryos
overexpressing XtSulf2, Pax6 expression spreads to include the
posterior and dorsal head ectoderm (asterisk, Figs. 3P and Q). This is
consistent with the BMP inhibiting activity we have found for XtSulf2,
as Pax6 expression is known to be restricted by BMP signalling
(Hartley et al., 2001).
Slug is expressed in the cranial neural crest (Fig. 3R), in embryos
unilaterally injected with XtSulf2 mRNA (Fig. 3S), Slug expression at
the leading edge of neural crest migration remains closer to the neural
tube than in controls (black lines). Sox3 is expressed in the neural tube
and the epibranchial and lateral line placodes, the branchial arches
and lens of the eye (Fig. 3T), while in embryos unilaterally injected
with XtSulf2 mRNA (Fig. 3U), some aspects of Sox3 expression appearnterior neural tissue and the cranial neural crest. One blastomere of a two-cell Xenopus
op to NF stage 28 and ﬁxed for in situ hybridization using En2 (A–B), Isl1 (C–D), Krox20
(V–W). En2 expression is shifted posteriorly on the injected side (A–B). Isl1 expression
expression in the heart (C–D). Krox20 expression in the migrating neural crest shifts
ion in the pronephros is restricted anteriorly (H–I black lines). NeuroD expression in the
lfactory placodes fuses with expression in the eye placodes (L yellow arrowheads). Otx2
ressed in the posterior and dorsal head ectoderm (O–P–Q red asterisk). Slug expression
ontrols (R–S black lines). Sox3 expression is decreased in neural crest but expands
is decreased and the leading edge of the migrating neural crest remains closer to the
ryos, anterior at the top. (C–F, H–K, M–P, R–W) are lateral views of embryos, anterior
e injected side. CS control side, IS injected side.
Fig. 4. XtSulf2 overexpression disrupts cranial neural crest migration. One blastomere of a two-cell X. tropicalis embryo was injected with 0.5 ng of XtSulf2 mRNA, embryos were
allowed to develop to NF stage 22 and 30 and ﬁxed for in situ hybridisation using HoxB3 (A–E), NeuroD (F–I), Slug (J–M), Sox8 (N–Q) and Twist (R–U). (A–B, F–G, J–K, N–O, R–S)
Lateral views of control and injected sides of NF stage 22 embryos. (E) Dorsal view of embryo in (A–B), black asterisk indicated the injected side. (C–D, H–I, L–M, P–Q, T–U) Lateral
views of control and injected sides of NF stage 30 embryos. At stage 22, on the control side 6–12% of embryos show disrupted migration, while on the injected side 58–71% of
migration is found to be inhibited (n=55–84) as assayed by the expression of CNCmarkers shown. At stage 30, on the control side 4–5% of embryos show disruptedmigration, while
on the injected side 40–53% of migration is found to be inhibited (n=34–81).
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lateral line placodes decreases, and expression in the branchial arch is
broadened (black lines). Sox8 is expressed in the trunk and cranial
neural crest (arrowheads, Fig. 3V), and in embryos overexpressing
XtSulf2 mRNA, Sox8 expression in the leading edge of the migrating
neural crest is decreased and remains closer to the neural tube than in
controls and expression in each branchial arch is no longer distinct
(arrowheads, Fig. 3W).
XtSulf2 overexpression results in the abnormal expression of cranial
neural crest markers
Notable among themarkers affected by XtSulf2 overexpression are
those expressed in the cranial neural crest (CNC). It is known that
Wnt, BMP and FGF signals (from both the ectoderm and the dorsal
mesoderm) are important in the early induction of the neural crest at
the boundary of the neural and non-neural ectoderm. To uncover any
early effects of XtSulf2 overexpression, we assayed the expression of
Slug at NF stage 15 and found that although Slug was still expressed,
there was a reduction of Slug expression levels in 54% of embryos
analysed (n=24). We also noted that the lateral boundary of Slug
expression is more diffuse in some embryos overexpressing XtSulf2
(Supplementary Fig. 3). These effects are unlikely to be due to
abnormal mesoderm formation as the injections are targeted to the
animal hemisphere and we have found that MyoD expression is
unaffected (data not shown).
To further investigate the impact of XtSulf2 on CNC migration,
embryos overexpressing XtSulf2 were analysed for changes in the
expression of HoxB3, NeuroD, Slug, Sox8 and Twist at NF stages 22 and
30. The results from these experiments are shown in Fig. 4. HoxB3 is
expressed in rhombomere 5 (r5) and in the emerging NC streamingfrom r5 (Figs. 4A and C). Embryos unilaterally injected with XtSulf2
mRNA show a posterior shift of HoxB3 expression in the neural tube
and reduced NC migration (Figs. 4B, D, and E). XtSulf2 injected
embryos also show a disruption of NeuroD expression in all the
neurogenic placodes and its expression is no longer conﬁned to the
deﬁned placodal areas (Figs. 4G and I). At later stages the antero-
dorsal lateral line and profundal placodes expression do not fuse
ventrally as they do normally (Figs. 4F–H).
Slug, Sox8 and twist are normally expressed in the three streams of
CNC targeting the mandibular, hyoid and branchial arches (Figs. 4J, N,
and R, and Figs. 4L, P and T). Analysis of these neural crest markers in
embryos overexpressing XtSulf2 unilaterally reveals the disruption of
NC migration into the hyoid and branchial arches (Figs. 4K, O and S
and Figs. 4M, Q and U), where both of these streams are not as clearly
deﬁned as compared to the uninjected side. At stage 30, the
expression of Slug is apparent in the stream anterior to the eye in
XtSulf2 injected embryos, whereas in controls the expression is seen
only caudal to the eye (Fig. 4M).
XtSulf1 and XtSulf2 are essential for the normal migration of the CNC
Our ﬁndings that ectopic Sulf activity affects normal CNC
migration, together with the normal expression of XtSulf1 in the
hyoid and branchial arches (Freeman et al., 2008, and Supplementary
data Fig. 4) and XtSulf2 in the pharyngeal endodermal pouch of
the hyoid arch, very close to the cement gland, from NF stage 22
(Supplementary data Fig. 4), suggest a role for this family of
extracellular sulphatases in normal CNC migration. To investigate
this possibility, we used antisense morpholino oligos (AMOs) to
knockdown the expression of XtSulf1 and XtSulf2 and analysed the
expression of genes expressed in the CNC (NeuroD, Sox8 and Twist).
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inhibits the translation of injected mRNA coding for a Myc-tagged
XtSulf2 (Supplementary data Fig. 5). The XtSulf1 AMO was described
previously (Freeman et al., 2008). The data from these experiments
are summarised in Table 1.
To determine any early effects of Sulf knockdown on neural
crest induction or on the dorsal mesoderm, NF stage 15 embryos
were analysed for the expression of Slug and MyoD. While XtSulf2
is not expressed until later than this in anterior neural tissue, XtSulf1
is expressed in the paraxial mesoderm and its depletion could
possibly affect signals from the dorsal mesoderm essential for neural
crest induction (Monsoro-Burq et al., 2003). We found that our injec-
tions targeting the morpholino oligos to the animal hemisphere
do not affect the expression of Slug or MyoD at neural plate stages
(Figs. 5A–D).
At NF stage 22, X. tropicalis embryos, uninjected or injected with a
control morpholino oligo (CMO), express NeuroD in the neurogenic
placodes (Figs. 5 E, F). Bilateral injection of an AMO directed against
XtSulf1 (S1 AMO), results in the loss of NeuroD expression in the lens
and profundal placode and disrupts the expression of NeuroD in the
trigeminal and antero-dorsal lateral line placode where instead of
the standard “V” shape, the placodes appear parallel and broader
(Fig. 5G). In embryos bilaterally injected with an AMO directed
against XtSulf2 (S2 AMO), NeuroD expression is decreased (Fig. 5H).
In embryos injected with AMOs targeting both XtSulf1 and XtSulf2
(S1/S2 AMO), NeuroD expression in the neurogenic placodes is noTable 1
AMO knockdown of XtSulf1 and/or XtSulf-2mRNA inhibits normal CNCmigration. Both
blastomeres at the two-cell stage were injected with a control MO or an AMO directed
against XtSulf1 or XtSulf2, or a combination of both AMOs. Embryos were left to
develop until NF stage 22 and NF Stage 30, ﬁxed and prepared for in situ hybridisation
for NeuroD, Sox8, and Twist. A minimum of two independent experiments were carried
out for each set of injections. Photographs of some of these embryos are shown in Fig. 5.
Normal
on both
sides
Failure to
migrate
on one side
Failure to
migrate on
both sides
Inhibition of
migration
(%)
Number
of embryos
(n)
NF stage 22
NeuroD Control 48 5 5 17 58
CMO 49 3 2 9 54
S1 AMO 20 23 15 65 58
S2 AMO 38 11 5 30 54
S1/S2 AMO 2 10 36 96 48
Sox8 Control 53 8 0 13 61
CMO 45 6 2 15 53
S1 AMO 31 21 6 46 58
S2 AMO 28 14 13 49 55
S1/S2 AMO 13 27 7 72 47
Twist Control 53 3 3 10 59
CMO 45 4 5 16 54
S1 AMO 18 28 7 66 53
S2 AMO 35 18 5 40 58
S1/S2 AMO 7 25 23 87 55
NF stage 30
NeuroD Control 35 0 0 0 35
CMO 30 3 3 17 36
S1 AMO 14 7 13 59 34
S2 AMO 36 6 3 20 45
S1/S2 AMO 8 11 9 71 28
Sox8 Control 33 0 3 8 36
CMO 3 3 5 19 41
S1 AMO 14 16 2 56 32
S2 AMO 33 7 4 25 44
S1/S2 AMO 17 13 9 56 39
Twist Control 35 0 1 3 36
CMO 31 3 2 13 36
S1AMO 16 12 6 53 34
S2 AMO 34 4 2 15 40
S1/S2 AMO 10 19 24 81 53longer distinguishable in 96% of the embryos (Fig. 5I). At NF stage 30,
NeuroD expression is similarly disrupted by these AMOs (Figs. 5T–X).
In uninjected control embryos and embryos injected with CMO
(Figs. 5J, K), Sox8 is expressed in the three streams of CNC. Embryos
bilaterally injected with S1 AMO show a similar disruption in Sox8
expression; in the mandibular arch it appears to be normal, but the
expression domain does not extend as far ventrally in the hyoid and
the branchial arches as compared to controls. Additionally, the
expression of Sox8 in the anterior and posterior branchial arches no
is no longer distinct, suggesting these structures have fused together
(Fig. 5A′), or that CNC migration to distinct arches has been delayed.
The expression of Sox8 is also fused in embryos where XtSulf2 is
knocked down (Fig. 5B′), however, this phenotype is less dramatic
than in those targeted for XtSulf1. The penetrance of the phenotype
for both morpholinos is roughly the same, 46% and 49%, respectively,
for S1 AMO and S2 AMO at NF stage 22 (Table 1). In embryos where
both XtSulf1 and XtSulf2 are knocked down (Fig. 5C′), Sox8
expression in the mandibular arch persists, however there is less
extension of Sox8 expression in the hyoid and branchial arches
where it remains close to the neural tube and does not separate into
distinct streams (72% of injected embryos). Consistent with the
results for NeuroD and Sox8 described above, the normal expression
level of twist in the arches is reduced in S1/S2 morphant embryos at
stage 22 (Fig. 5S); twist expression in the mandibular arch appears
relatively normal, while expression in the hyoid and branchial arches
does not extend ventrally and the expression in the branchial arches
does not appear as two distinct entities, but is fused together in
knockdown embryos (Figs. 5Q–S). By stage 30, there is some
recovery of expression in the arches, suggesting that migration of
the CNC may be delayed in morphant embryos. Still, reduced
expression of Sox8 and twist remains evident in the XtSulf1 and
XtSulf1/2 knockdown embryos at stage 30 (Figs. 5 A′, C′, F′, and H′).
Interestingly, there is increased expression of Sox8 in the somites of
stage 30 embryos injected with AMO against XtSulf1, suggesting a
further role for XtSulf1 in regulating the migration of NC in the trunk,
which is consistent with the expression of XtSulf1 in the somites
(Freeman et al., 2008).
XtSulf2 is not expressed until late neural stages in the anterior
neural tube, however XtSulf1 is expressed zygotically in the paraxial
mesoderm until late neural stages when its expression continues in
the somites andmesoderm and is activated in the ﬂoorplate (Freeman
et al., 2008). It is therefore possible that XtSulf1 plays a role in the
posterior FGF and Wnt signalling involved in specifying neural crest
formation (LaBonne and Bronner-Fraser, 1998). In order to speciﬁ-
cally knockdown XtSulf1/2 only in cells giving rise to neural tissue,
and avoid any effects of losing XtSulf1 activity in the mesoderm, we
injected AMOs against Sulf1 and Sulf2 into the dorsal blastomeres in
the animal hemisphere at the 8-cell stage (Fig. 6). The embryos were
analysed by in situ hybridisation at stages 16, 22 and 30. We found no
effect on neural crest induction or on the early mesoderm as assayed
by the expression of slug (Figs. 6A, C) or MyoD (Figs. 6B, D) at neurula
stages. At stage 22, there is a signiﬁcant disruption of twist expression
(Figs. 6E, F), revealing an interference with neural crest migration
while the expression of myoD (Figs. 6G, H) and α-cardiac actin
(Figs. 6I, J) in the somites is normal. At stage 30, severe shortening
of the axis is apparent, and while the expression of twist is now
evident in the branchial arches, it is reduced and irregular as compared
to controls (Figs. 6K, L). The shorter axes seen in the morphant
embryos at stage 30have developed regular somites anddifferentiated
skeletalmuscle as evident by the expression ofmyoD (Figs. 6M, N) and
α-cardiac actin (Figs. 6O, P; see also Supplementary data Fig. 6). In
summary, we ﬁnd that the targeted injections at the 8-cell stage result
in the same effect on neural crest migration, as shown by twist
expression, without affecting mesoderm formation or skeletal muscle
differentiation as analysed by MyoD (Figs. 6G, H, M and N) and α-
cardiac actin (Figs. 6I, J, O and P) expression.
Fig. 5. XtSulf1/2 double knockdown embryos show impaired early migration of the cranial neural crest. Xenopus tropicalis embryos were injected at two and four-cell stage into the
animal hemisphere. Sibling embryos were cultured until NF stage 15 (top panels), stage 22 (middle panels) and NF stage 30 (bottom panels) and ﬁxed for in situ hybridisation. This
ﬁgure shows control uninjected embryos (E, J, O, T, Y, D′); embryos injected with 30 ng of control morpholino oligo (CMO) (A, C, F, K, P, U, Z, E′); embryos injected with 10 ng of
antisense morpholino oligo (AMO) targeted against XtSulf1 (G, L, Q, V, A′, F′); embryos injected with 20 ng of AMO targeted against XtSulf2 (H, M, R, W, B′, G′); and embryos co-
injected with 10 ng of AMO targeted against XtSulf1and 20 ng of AMO targeted against XtSulf1(B, D, I, N, S, X, C′, H′). Top panels (A–D) are dorsal views, the others are lateral views
with anterior to the left. At stage 15, the expression of Slug marks the prospective neural crest at the boundary of the neural plate and the non-neural ectoderm (A, B). MyoD marks
the dorsal, paraxial mesoderm (C, D). The expression of these genes is not effected when embryos are injected into the animal hemisphere with AMOs targeting XtSulf1 and XtSulf2
(B, D). At stage 22, NeuroD is expressed in the profundal, trigeminal and antero-dorsal lateral line placodes and lens (E,F). In single XtSulf1 knockdown, NeuroD expression in these
placodes is reduced and disorganised (G), while in double Sulf knockdown, NeuroD expression is further reduced and restricted to a very small dorsal region (L). Sox8 and Twist are
expressed in the mandibular (around the eye), hyoid and branchial arches (J, K, O, P; three arrow heads) at NF stage 22. In single XtSulf1 and XtSulf2 knockdown embryos the
expression of these markers in the mandibular arch appears normal, but the expression in the hyoid and branchial arches does not extend as far ventrally as controls (L, M, R, Q;
arrowhead and line). The anterior and posterior branchial arches are no longer visible as two distinct entities. In double Sulf1/2 knockdowns, Sox8 and Twist expression in the
mandibular arch is normal, but expression in the hyoid and branchial arches is further restricted dorsally and the anterior and posterior branchial arches appear as one fused domain
(N and S, arrowhead and line). At NF stage 30, NeuroD is expressed normally in the neural placodes and pineal gland (T,U). In XtSulf1 single knockout, expression in the antero-dorsal
lateral line and trigeminal placodes migrate abnormally, all other expression is absent (V). In XtSulf2 knockouts, NeuroD expression is absent from the posterior lateral line placode,
and expression in the trigeminal and antero-dorsal lateral line placode appear closer together (W). In double Sulf knockouts, NeuroD is expressed abnormally in the antero-dorsal
lateral line and trigeminal placodes (X). Sox8 and Twist are expressed in the mandibular, hyoid and branchial arches (Y, Z, D′, E′). In single knockouts, the expression in the
mandibular arch appears normal, but the expression in the hyoid and branchial arches is restricted dorsally. Furthermore, the anterior and posterior branchial arches appear fused
together (A′, B′, F′, G′). In double Sulf knockouts, Sox8 and Twist expression domains are restricted dorsally in the hyoid and branchial arches, and the expression is fused in the
anterior and posterior branchial arches (C′, H′). The effects of XtSulf 1/2 knockdown on CNC migration as assayed by the expression of the markers shown in this ﬁgure are
summarised in Table 1.
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Fig. 6. Targeting XtSulf1/2 knockdown to neural tissue disrupts cranial neural crest migration and does not affect mesoderm differentiation. X. tropicalis embryos were injected
into the two dorsal blastomeres in the animal hemisphere at the 8-cell stage with 30 ng of control morpholino (CMO) or with 10 ng of S1 AMO together with 20 ng of S2 AMO
(S1/S2 AMO). At stage 16, CMO injected (A, B) and S1/S2 AMO injected (C, D) embryos show normal expression of slug (CMO=78% normal, n=23; S1/S2 AMO=59% normal,
n=17) and MyoD (CMO=90% normal, n=20, S1/S2 AMO=65% normal; n=23). At stage 22, twist expression is disrupted in knockdown embryos (F, 66% disrupted twist
expression, n=15) and does not extend as far ventrally as seen in those injected with control morpholino (E). The expression of myoD and α-cardiac actin in CMO injected
embryos at stage 22 are shown in G and I. There is normal expression of myoD (66%, n=18) and α-cardiac actin (64%, n=14) in S1/S2 knockdown embryos (H and J). (K) The
expression of twist in embryos injected with control morpholino at stage 30. (L) Twist expression is disrupted in knockdown embryos (69%, n=16). The expression ofmyoD and
α-cardiac actin in CMO injected embryos at stage 30 are shown in M and O. There is normal somite expression ofmyoD (83%, n=12) and α-cardiac actin (80%, n=10) in stage 30
S1/S2 knockdown embryos (N and P).
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knockdown embryos
To conﬁrm the speciﬁcity of our gene inhibition experiments, we
have rescued the S1/S2 morphant embryos by co-injecting mRNA
coding for XtSulf2 (Fig. 7). As Sulf1 and Sulf2 share enzymatic activity
and substrate speciﬁcity (Ai et al., 2006), expressing either should be
sufﬁcient to provide the missing enzyme activity to the knockdown
embryos (see also, Supplementary data Fig. 5). X. tropicalis embryos
were injected with CMO, S1/S2 AMO, or S1/S2 AMO plus XtSulf2
mRNA. Embryos were allowed to develop until NF stage 22 or 30 at
which point they were analysed for the expression of the NC marker
twist. Figs. 7A and B are controls showing the normal expression of
twist in embryos at NF stage 22 and 30 and injection of CMO does not
affect twist expression (Figs. 7C, D).XtSulf1/2 double knockdown embryos at NF stage 22 show a
signiﬁcant disruption of CNC migration as assessed by twist
expression (Fig. 7E), where the leading edge of the NC streams is
strongly perturbed, remaining close to the neural tube, and both hyoid
and branchial streams are not as clearly deﬁned as in control embryos.
Co-injection of mRNA coding for XtSulf2 restores the migration of the
NC (Fig. 7G). The expression of twist in the anterior and posterior
branchial arches is rescued by the co-injections of XtSulf2 mRNA and
the leading edge of the streams targeting the hyoid and branchial
arches is comparable to that of control uninjected embryos. Inhibition
of NC migration occurs in 70% of Sulf double knockdown NF stage 22
embryos compared to only 46% of embryos co-injected with XtSulf1
mRNA (Table 2).
By NF stage 30, there has been some migration of NC cells into the
branchial arches of XtSulf1/2 double knockdown embryos, although
Fig. 7. Delay in cranial neural crest migration in XtSulf1/2 double knockdown embryos
is rescued by XtSulf2 mRNA injections. The CNC migrates into the mandibular, hyoid
and anterior and posterior branchial arches in control and CMO embryos (A–D). In Sulf
1/2 double knockdown embryos, the CNC migration is blocked (E–F), migration is
rescued with XtSulf2 mRNA (G–H). Xenopus tropicalis embryos were injected at the
two- and four-cell stage into the animal hemisphere with either 30 ng of CMO (C, D),
10 ng of S1 AMO and 20 ng of S2 AMO (E, F) or 10 ng of S1 AMO, 20 ng of S2 AMO and
1.5 ng of XtSulf-2 mRNA (G, H). Neural crest migration was assayed by analysing Twist
expression by in situ hybridisation. All panels show lateral views with anterior to the
left. A summary of the results shown in this ﬁgure are reported in Table 2.
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in control embryos and the expression domain of twist is shorter and
less clearly deﬁned than in control embryos (Fig. 7F). Rescue of XtSulf
1/2 knockdown embryos by co-injecting XtSulf2 mRNA was analysed
at NF stage 30 and we ﬁnd that NC migration is largely restored
(Fig. 7H). Inhibition of NC migration occurs in 58% of XtSulf 1/2
double knockdown embryos at NF stage 30 while only 35% of stage 30
embryos co-injected with XtSulf2 mRNA show a defect in NC
migration (Table 2).Table 2
Injection of XtSulf-2 mRNA rescues NC migration in XtSulf1/2 knockdown embryos.
Embryos were injected with CMO, or co-injected with AMOs directed against both
XtSulf1 and XtSulf2, or co-injected with both AMOs and mRNA coding for XtSulf2.
Embryos were allowed to develop to NF stage 22 and NF stage 30 and ﬁxed for in situ
hybridisation to analyse the expression of Twist. A minimum of two independent
experiments were carried out for each set of injections. Photographs of some of these
embryos are shown in Fig. 7.
Normal on
both sides
Failure to
migrate on
one side
Failure to
migrate on
both sides
Inhibition of
migration (%)
Number of
embryos
(n)
NF stage 22
Control 118 0 14 10 132
CMO 114 9 0 7 123
S1/S2 AMO 31 47 26 70 104
S1/S2 AMO+
XtSulf-2 mRNA
51 36 8 46 95
NF stage 30
Control 125 1 6 5 132
CMO 106 3 4 6 113
S1/S2 AMO 56 11 67 58 134
S1/S2 AMO+
XtSulf-2 mRNA
56 24 6 35 86XtSulf2 activity can disrupt normal CNC migration
To determine whether XtSulf2 activity affects NC migration cell
autonomously or non-cell autonomously, a series of grafting experi-
ments using NC explants were undertaken (Fig. 8). The experiments
carried out are depicted by the cartoons in Fig. 8. Explants were taken
from the neural plate border of NF stage 14 X. laevis embryos injected
with mRNA coding for GFP and grafted into the same stage control
hosts (Figs. 8A–C) or hosts injected with XtSulf2 (Figs. 8D–F). To
conﬁrm that NC was being explanted, we analysed some of these
explants for the expression of the neural crest marker Slug
(Supplementary data Fig. 7). Embryos were left to develop until NF
stage 30 and analysed by ﬂuorescent confocal microscopy to reveal
the migration of GFP expressing grafted cells. Control explants
migrate normally in a control background along any of the three
main neural crest streams (Figs. 8A–C). In contrast, the migration of
NC explants in an XtSulf2 injected host embryo is inhibited and
grafted cells do not migrate normally (Figs. 8D–F). Inhibition of
migration is seen in 64% of NC explants grafted into XtSulf2 injected
embryos (n=106).
In a complementary experiment, NC explants were taken from
embryos co-injected with mRNAs coding for GFP and XtSulf2,
transplanted to the same region of an uninjected host embryo at the
same stage and allowed to develop to NF stage 30. Figs. 8G–I shows
the migration of XtSulf2/GFP expressing grafts in a control host,
where normal migration is seen in 80% of the transplants (n=30).
These data indicate that XtSulf2 overexpression effects CNCmigration
non-cell autonomously.We conclude that excess XtSulf2 in grafted NC
cells does not affect their migration; however, when XtSulf2 is
ectopically expressed in the environment through which the NC
moves, there is a disruption of migration.
Neural crest migration requires Sulf activity non-cell autonomously
To further investigate the requirement for XtSulf1/2 for normal
neural crest migration, explants were taken from the neural plate
border of NF stage 15 X. tropicalis embryos injectedwithmRNA coding
for GFP alone or together with the antisense morpholino oligos
targeting XtSulf1 and XtSulf2 (S1/S2 AMO) described above. Explants
from control GFP expressing embryos or embryos injected with GFP
mRNA and Sulf1/2 AMOs were grafted isotopically into the same
stage control hosts. In another experiment, GFP explants were
transplanted into the same stage Sulf1/2 knockdown hosts. In
controls, cells from GFP grafts migrate to the arches (70% full
migration to arches, n=10) (Figs. 8 J–L). When XtSulf1 and 2 are
knocked down in the grafted cells, there is some migration in most
specimens (45% good migration, 40% less extensive migration
(shown), 15% no migration; n=13), although overall it is less robust
than controls (Figs. 8 M–O). When wild type cells are grafted into S1/
S2 knockdown hosts, the cells move extensively but there is very little
direction to the migration and no clear streams are seen (80%, n=15)
(Figs. 8 P–R). Taken together, data from our grafting experiments
indicate that the Sulf enzymes are important in the cellular
environment through which the neural crest migrates.
Discussion
We have found that XtSulf1 and XtSulf2 are required for the
normal migration of the neural crest in Xenopus embryos. Interest-
ingly, the loss of the human orthologue of Sulf1 (HSulf-1) also results
in motility changes in some carcinoma cell lines (Lai et al., 2004).
Common molecular mechanisms have been found to underpin the
ability of both NC cells and metastatic cancer cells to migrate
extensively through the body of an organism (Kuriyama and Mayor,
2008). Indeed, humanmetastatic melanoma cells have been found to
behave as NC cells when exposed to the same environment when
Fig. 8. Grafting experiments reveal a requirement for XtSulf1/2 in the environment through which cranial neural crest cells migrate. On the left, cartoons depict the design of the
neural crest grafting experiments, while the panels to the right show the resulting embryos at tailbud stages. The top set of experiments show X. laevis embryos injected at the two-
cell stage with 0.5 ng of GFP mRNA, ±3 ng of mRNA coding for XtSulf2 and from which are dissected CNC explants at NF stage 14. Explants are transplanted into either a control
embryo or an embryo injected with 3 ng of XtSulf2 mRNA. (A–C) Control host embryos transplanted at NF stage 14 with GFP expressing neural crest explants. (D–F) Host embryos
injected with 3 ng of XtSulf2 at the two-cell stage into the animal pole and grafted with GFP expressing CNC explants at NF stage 14. (G–I) Control X. laevis host embryos grafted at NF
stage 14 with GFP+XtSulf2 expressing CNC explants. All pictures were taken at 10X magniﬁcation; the eye, cement gland, and labelled cells are outlined. The bottom set of
experiment show X. tropicalis embryos injected with mRNA coding for GFP±AMOs targeted against XtSulf1 and XtSulf2. (J–L) At NF stage 15, CNC explants were taken from control
Xenopus tropicalis embryos expressing GFP and transplanted into uninjected control embryos at the same stage. The GFP labelled cells migrate into the branchial arches by NF stage
30. (M–O) GFP mRNA together with AMOs targeting both XtSulf1 and XtSulf2 were injected into the animal hemisphere at the 2-cell stage and at NF stage 15 CNC explants were
transplanted into control host embryos at the same stage. Labelled S1/S2 knockdown cells migrate less extensively than the control cells, but have direction. (P–R) At NF stage 15,
CNC explants were taken from control Xenopus tropicalis embryos expressing GFP and transplanted into host embryos in which XtSulf1 and XtSulf2 have been knocked down. At
stage 30, labelled cells are seen to be widely dispersed, suggesting that these wildtype cells lack direction in the S1/S2 mutant background. The eye, cement gland, and labelled cells
are outlined.
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Similar molecular mechanisms underlie the changes in cell adhesion
and morphology in NC cells delaminating from the dorsal neural
tube and invasive tumour cells, including the activation of the tran-
scription factors Snail and Twist and the down-regulation of E-
caherin. HSulf-1 and HSulf-2 have been shown to be mis-regulated
in a number of cancers (reviewed by Sanderson et al., 2005), and
while some effects of abnormally high or low Sulf enzyme activity
would be changes in cellular response to signalling, our work here
suggests that, in addition, changes in Sulf expression could affect cell
migration.Mice with targeted deletions of Sulf1 and Sulf2 die post-natally
which is in part due to the lack of GDNF-dependent innervation of
the oesophagus (Ai et al., 2007). GDNF signalling has also been im-
plicated in the directional migration of NC cells (Heuckeroth et al.,
1998; Young et al., 2001) supporting the possibility that Sulf1 is
important for neural crest migration in other vertebrates as well. Like
their mammalian orthologues, XtSulf2 and XtSulf1 edit local HSPGs
thereby modulating the activity of multiple signalling pathways, and
in Xenopus these include Wnt, BMP and FGF (Fig. 2; Freeman et al.,
2008). The Sulf family of enzymes present a new level for regulating
cell signalling. Unlike most extracellular inhibitors of cell signalling,
386 E.C. Guiral et al. / Developmental Biology 341 (2010) 375–388Sulfs do not directly interact with ligands, instead, Sulfs speciﬁcally
remove sulphates from 6-O trisulphated residues on HSPGs, which
inﬂuences the ability of HSPGs to bind growth factors or affects their
interaction with cell surface receptors. We have shown that over-
expressing XtSulf2 inhibits NC migration, but given their similar
biochemical activities, it is very likely that either XtSulf1 or XtSulf2
would be equally effective in doing so. To distinguish the roles of
these enzymes in normal NC migration in vivo, XtSulf1 and XtSulf2
were knocked down individually and together. Transcripts coding for
both enzymes are present in the embryo during CNC migration:
XtSulf1 is highly expressed in the hyoid and branchial arches cells
from early tailbud stages, and XtSulf2 is expressed in the mandibular
endodermal pouch (see Supplementary data Fig. 4). More dramatic
effects on the expression of neural crest markers were seen in
embryos lacking XtSulf1, indicating that the expression of XtSulf1 is
critical for their normal migration. Embryos in which XtSulf2 was
targeted had smaller effects on NC migration as assayed by the
expression of NeuroD, Sox8 and twist (Fig. 5), however when both
XtSulf1 and XtSulf2 are knocked down together, the disruption of
these markers is more dramatic, supporting a role for XtSulf2 in these
processes.
It is possible that early Sulf activity is important for some aspects
of neural induction and patterning that contributes to the poor
neural crest migration seen in later embryos. As Sulf activity can
inﬂuence many signalling pathways required for normal develop-
ment, Sulf could impact NC migration at multiple levels including
earlier events in neural patterning as well as the structure of the
extracellular environment through which the NC migrates. XtSulf2 is
not expressed until late neural stages in the anterior neural tube
(Fig. 1). XtSulf1 is expressed zygotically in the paraxial mesoderm
until late neural stages when its expression continues in the somites
and mesoderm and is activated in the ﬂoorplate (Freeman et al.,
2008). The late expression of XtSulf2 rules out any role in neural crest
induction, however, XtSulf1 is in a good position to mediate the
posterior FGF and Wnt signalling involved in specifying where the
neural crest forms (Labonne and Bronner-Fraser, 1998). We have
addressed this by targeting only cells fated to be neural by injecting
the two dorsal blastomeres in the animal hemisphere at the 8-cell
stage, thereby avoiding any effects of knocking-down Sulf in the
mesoderm (Fig. 6). In this set of experiments, there is a disruption
NC migration as seen by the disrupted expression of twist, but there
is still robust expression of myoD and α-cardiac actin in the somites.
However, there is still a possibility that Sulf activity is required
earlier in the neural plate during the multi-step process that results
in the neural crest forming along the posterior neural folds (Li et al.,
2009).
Neural crest–HSPG interactions
The remodeling of cell surface HSPGs by Sulf activity may provide
an essential adhesive character necessary for directed NC cell
migration, allowing interaction of the CNC with a permissive
extracellular matrix (Henderson and Copp, 1997). A substantial
amount of work suggests that interactions between the NC and the
ECM are crucial to NC migration (Perris and Perissinotto, 2000), for
example, studies in chick have shown that a laminin–HSPG complex is
present in the mesenchyme into which NC cells migrate and
disruption of this laminin–HSPG complex perturbs normal NC
migration (Bronner-Fraser and Lallier, 1988). More recently, work in
Xenopus has shown thatMyosin-X is required for the neural crest cells
to adhere with one another and with the surrounding ECM; neural
crest cells lacking this ability fail to migrate (Nie et al., 2009). Our
results indicate that the presence of Sulf enzymes is required in the
cells through which or to which the CNC migrates, suggesting that
XtSulf1 and XtSulf2 shape the speciﬁc character of the HSPGs on the
surface of the cells along the migration track.Grafts of Sulf1/2 knockdown CNC cells migrated less well than
wildtype cells (Figs. 7M–O), suggesting a possible role in the CNC
itself. Syndecan-4 (Syn-4) is an HSPG that is expressed speciﬁcally in
the neural crest and has been shown to be essential for normal NC
migration in vivo in both frogs and ﬁsh (Matthews et al., 2008). Syn4 is
known to regulate the Wnt planar cell polarity (PCP) pathway
(Alexopoulou et al., 2007) and it is possible that XtSulf1 further
promotes PCP signalling in migrating NC cells. Non-canonical Wnt
signalling has been shown to be essential for NC migration, where
gain and loss of function experiments with Wnt11 andWnt11R result
in the failure of neural crest migration (De Calisto et al., 2005;
Matthews et al., 2008). Sulf1 expressing cells have been shown to be
enhanced in their ability to respond to canonical Wnt signalling (Ai
et al., 2003; Dhoot et al., 2001), and co-injection of mRNA coding for
Sulf1 and Wnt11 into Xenopus embryos dramatically increases the
occurrence of secondary axes (Freeman et al., 2008) indicating that
the presence of Sulf1 promotesWnt signalling. No studies have looked
at the ability of Sulf1 to impact non-canonical Wnt signalling;
however, because Sulf1 is active at the level of ligand/receptor
interaction, it is possible that there is a similar promotion of both
intracellular pathways downstream of Frizzled.
Eph signalling
Cephalic neural crest cells are restricted into distinct streams prior
to and during their migration, and ephrins and Eph receptors are
considered key in preventing intermingling of these streams. In
Xenopus, EphA4 and EphB1 are expressed in the third branchial arch,
while the transmembrane ligand, ephrinB2 is expressed in the second
arch and provides a repulsive cue. Blocking or mis-expression of Eph
receptors or ephrin ligands causes speciﬁc defects in NC migration
(Smith et al., 1997). Recently, HSPGs have been shown to play a role in
Eph receptor signalling (Irie et al., 2008) opening the possibility for a
further layer of regulation by Sulf enzymes. Similar to effects of
truncated Eph receptors, overexpression of XtSulf2 caused disruption
of neural crest migration into the second and third branchial arches
and intermingling of the NC streams as assayed by twist and Sox8
expression. It is possible that the Sulf enzymes modulate Eph
signalling and contribute to the restriction of Eph activity to particular
cells.
FGF signalling
An alternative or additional mechanism for Sulf enzymes im-
pacting NC migration could be through their modifying HSPG
structure to impact on local FGF signalling. The interaction of FGF
ligand with its receptor is known to require the presence of HSPGs
and, in particular, the 6-O-sulphate group on glucosamine residues
has been found to be essential for this interaction. Consistent with
this, Sulf1 has been shown to inhibit FGF signalling in embryos and
in a pancreatic cancer cell line (Freeman et al., 2008; Li et al., 2005;
Wang et al., 2004). Furthermore, FGFs are known to be important in
the development of NC derivatives in zebraﬁsh (Crump et al., 2004).
In Xenopus, FGFs are expressed in the branchial arches (Christen and
Slack, 1997; Lombardo et al., 1998) and here we show the expression
of FGF3 and FGF8 in the endodermal out-pocketings perfectly
complement the expression of XtSulf1 in the neural crest (Supple-
mentary data Fig. 4). FGF signalling is known to be important for NC
migration and has been suggested to act as a chemoattractant
(Kubota and Ito, 2000). In zebraﬁsh FGF3−, FGF8− loss-of-function
embryos, there is a complete loss of endodermal pouches and an
absence of hyoid and branchial cartilages (Crump et al., 2004;
Walshe and Mason, 2003). Consistent with this, hypomorphic FGF8
mutant mice and the zebraﬁsh acerebellar mutants display a wide
range of cranial abnormalities including defects in cartilage and bone
formation (Abu-Issa et al., 2002; Reifers et al., 1998). These data
387E.C. Guiral et al. / Developmental Biology 341 (2010) 375–388support the notion that FGFs are essential for the development of the
cranial NC. XtSulf1 and XtSulf2 are expressed in the pharyngeal arch
region adjacent to FGF3 and FGF8 expression and thus may play an
important role in creating boundaries and restricting FGF signalling
in the pharyngeal pouches. Furthermore, in mouse, BMP7 is also
expressed in the posterior endodermal pouch (Veitch et al., 1999)
and overexpression of the BMP regulator crossveinless-2 impacts
neural crest migration in chick embryos (Coles et al., 2004). Thus
Sulfs may act to locally restrict BMP and/or FGF signalling in the
pharyngeal pouches to modulate the environment through which
the crest migrates.
We have shown here, using multiple probes to mark the cephalic
neural crest, that XtSulf2 overexpression results in the fusion of neural
crest streams. In addition, XtSulf1/2 morphant embryos also display
disrupted NC migration and a fusion of NC streams. In grafting
experiments, excess XtSulf2 in the NC cells has little effect on their
ability to migrate, while expressing XtSulf2 widely in the host
prevents the majority of grafts from migrating. Furthermore, cells in
which Sulf is knocked down migrate with some direction in a
wildtype background, whilewildtype cells in an S1/ S2morphant host
disperse andmigrate widely andwith no apparent direction. Together
these data support the view that both the restricted expression and
non-expression of XtSulf1 and XtSulf2, in the region of NCC migration
is critical for directed cell movement.
A recent report showed that when NC cells come into contact with
other NC cells, their lamellapodia collapse and they change the direction
of their migration, however, this doesn't happen when NC cells come
into contact with other cell types (Carmona-Fontaine et al., 2008). NC
cells migrate as groups that are polarized by interactions within the
group, and invade regions made up of other types of cells, such as
mesoderm. Together these cell behaviours go someway to explaining a
mechanism for directionality of migration: closely associated groups of
NC cellsmoving intoNC-free zones. Key to thismodel is thatNC cells are
distinguishable at the cell surface from non-NC cells. The characteristic
cell surface of NC cells distinct from that of the cells in the environment
through which they migrate may in part be provided for by the activity
of XtSulf1 and XtSulf2, thus allowing the NC to migrate in cohesive
streams. The activity of Sulf enzymes changes the nature of the cell
surface by restructuring HSPGs; this could have direct effects on NC
migrationby impacting cell behaviouror cell–cell interaction in addition
to or outside of any inﬂuence on cell signalling.
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